Skyrizi 150 mg (Risankizumab)

Skyrizi (risankizumab) is a biologic therapy for Crohn's disease and related inflammatory conditions. We source it as pharmaceutical-grade medication, verified through a licensed Colombian physician and aligned with INVIMA/FDA standards.

Each box includes 1 prefilled pen, for subcutaneous injection. Taxes and customs are included.